Serveur d'exploration sur la maladie de Parkinson

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Eléments de l'association

J. P. Larsen17
Parkinson's disease1301
J. P. Larsen Sauf Parkinson's disease" 7
Parkinson's disease Sauf J. P. Larsen" 1291
J. P. Larsen Et Parkinson's disease 10
J. P. Larsen Ou Parkinson's disease 1308
Corpus4598
\n\n\n\n \n

List of bibliographic references

Number of relevant bibliographic references: 10.
Ident.Authors (with country if any)Title
000750 G. O. Skeie [Norvège] ; B. Muller [Norvège] ; K. Haugarvoll [Norvège] ; J. P. Larsen [Norvège] ; O. B. Tysnes [Norvège]Differential effect of environmental risk factors on postural instability gait difficulties and tremor dominant Parkinson's disease
001206 M. Horstink [Pays-Bas] ; E. Tolosa [Espagne] ; U. Bonuccelli [Italie] ; G. Deuschl [Allemagne] ; A. Friedman [Pologne] ; P. Kanovsky [République tchèque] ; J. P. Larsen [Norvège] ; A. Lees [Royaume-Uni] ; W. Oertel [Allemagne] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; C. Sampaio [Portugal]Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies and the Movement Disorder Society–European Section. Part I: early (uncomplicated) Parkinson's disease
001207 M. Horstink [Pays-Bas] ; E. Tolosa [Espagne] ; U. Bonuccelli [Italie] ; G. Deuschl [Allemagne] ; A. Friedman [Pologne] ; P. Kanovsky [République tchèque] ; J. P. Larsen [Norvège] ; A. Lees [Royaume-Uni] ; W. Oertel [Allemagne] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; C. Sampaio [Portugal]Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies (EFNS) and the Movement Disorder Society‐European Section (MDS‐ES). Part II: late (complicated) Parkinson's disease
001318 C. Vossius [Norvège] ; M. Gjerstad [Norvège] ; H. Baas [Allemagne] ; J. P. Larsen [Norvège]Drug costs for patients with Parkinson's disease in two different European countries
001404 K. Haugarvoll [Norvège] ; D. Aarsland [Norvège] ; T. Wentzel-Larsen [Norvège] ; J. P. Larsen [Norvège]The influence of cerebrovascular risk factors on incident dementia in patients with Parkinson's disease
001695 K. Herlofson [Norvège] ; J. P. Larsen [Norvège]The influence of fatigue on health‐related quality of life in patients with Parkinson's disease
001769 M. Kurz ; G. Alves ; D. Aarsland [Norvège] ; J. P. LarsenFamilial Parkinson's disease: a community‐based study
001D66 D. Aarsland [Norvège] ; J. P. Larsen [Norvège] ; K. Karlsen [Norvège] ; N. G. Lim [Norvège] ; E. Tandberg [Norvège]Mental symptoms in Parkinson's disease are important contributors to caregiver distress
002033 V. V. Myllyl [Finlande] ; M. Jackson [Royaume-Uni] ; J. P. Larsen [Norvège] ; H. Baas [Allemagne]Efficacy and safety of tolcapone in levodopa‐treated Parkinson's disease patients with “wearing‐off” phenomenon: a multicentre, double‐blind, randomized, placebo‐controlled trial
002448 J. P. Larsen [Norvège] ; E. Dupont [Danemark] ; E. Tandberg [Norvège]Clinical diagnosis of Parkinson's disease. Proposal of diagnostic subgroups classified at different levels of confidence

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 18:06:51 2016. Site generation: Wed Mar 6 18:46:03 2024